313 related articles for article (PubMed ID: 24319191)
21. [Prediction of the splenectomy efficacy in chronic immune thrombocytopenic purpura].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):119-35. PubMed ID: 16405235
[TBL] [Abstract][Full Text] [Related]
22. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: Differentiating from bone marrow failure and predicting bleeding risk.
McDonnell A; Bride KL; Lim D; Paessler M; Witmer CM; Lambert MP
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921855
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura.
McFarland J
Blood Rev; 2002 Mar; 16(1):1-2. PubMed ID: 11913982
[TBL] [Abstract][Full Text] [Related]
25. Novel Murine Model of Immune Thrombocytopaenia through Immunized CD41 Knockout Mice.
Li X; Wang SW; Feng Q; Hou Y; Lu N; Ma CH; Gao CJ; Hou M; Peng J
Thromb Haemost; 2019 Mar; 119(3):377-383. PubMed ID: 30630213
[TBL] [Abstract][Full Text] [Related]
26. Megakaryocyte apoptosis in immune thrombocytopenia.
Vrbensky JR; Nazy I; Toltl LJ; Ross C; Ivetic N; Smith JW; Kelton JG; Arnold DM
Platelets; 2018 Nov; 29(7):729-732. PubMed ID: 29787328
[TBL] [Abstract][Full Text] [Related]
27. [TREATMENT OF IMMUNE THROMBOCYTOPENIC PURPURA IN ADULTS: UPDATE].
Blickstein D
Harefuah; 2019 Mar; 158(3):196-199. PubMed ID: 30916510
[TBL] [Abstract][Full Text] [Related]
28. Management of immune thrombocytopenic purpura in adults.
Stasi R; Provan D
Mayo Clin Proc; 2004 Apr; 79(4):504-22. PubMed ID: 15065616
[TBL] [Abstract][Full Text] [Related]
29. Recognizing and treating secondary immune thrombocytopenic purpura associated with lymphoproliferative disorders.
Liebman HA
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S33-6. PubMed ID: 19245932
[TBL] [Abstract][Full Text] [Related]
30. Current options for the treatment of idiopathic thrombocytopenic purpura.
Arnold DM; Kelton JG
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow examination in patients with immune thrombocytopenia: is there anything different in older patients?
Gunduz E; Kivanc BK; Arik D; Isiksoy S; Bal C; Akay OM
Eur J Haematol; 2014 Aug; 93(2):157-60. PubMed ID: 24660825
[TBL] [Abstract][Full Text] [Related]
32. Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk.
Middelburg RA; Carbaat-Ham JC; Hesam H; Ragusi MA; Zwaginga JJ
Hematology; 2016 Oct; 21(9):549-51. PubMed ID: 27159138
[TBL] [Abstract][Full Text] [Related]
33. Pathophysiology of Autoimmune Thrombocytopenia: Current Insight with a Focus on Thrombopoiesis.
Marini I; Bakchoul T
Hamostaseologie; 2019 Aug; 39(3):227-237. PubMed ID: 30802916
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.
Adly AA; Ragab IA; Ismail EA; Farahat MM
Platelets; 2015; 26(7):645-50. PubMed ID: 25350586
[TBL] [Abstract][Full Text] [Related]
35. Idiopathic thrombocytopenic purpura and dysmegakaryocytopoiesis.
Wang L; Li Y; Hou M
Crit Rev Oncol Hematol; 2007 Nov; 64(2):83-9. PubMed ID: 17900920
[TBL] [Abstract][Full Text] [Related]
36. Clinical updates in adult immune thrombocytopenia.
Lambert MP; Gernsheimer TB
Blood; 2017 May; 129(21):2829-2835. PubMed ID: 28416506
[TBL] [Abstract][Full Text] [Related]
37. Immune thrombocytopenic purpura: the treatment paradigm.
Stasi R
Eur J Haematol Suppl; 2009 Mar; (71):13-9. PubMed ID: 19200303
[TBL] [Abstract][Full Text] [Related]
38. [Thrombocytopenia in newborn infants caused by autoimmune thrombocytopenic purpura in their mothers].
Mordasewicz-Goliszewska M
Wiad Lek; 1992 Apr; 45(7-8):270-4. PubMed ID: 1462587
[TBL] [Abstract][Full Text] [Related]
39. Massive platelet transfusion is a rapidly effective emergency treatment in patients with refractory autoimmune thrombocytopenia.
Salama A; Kiesewetter H; Kalus U; Movassaghi K; Meyer O
Thromb Haemost; 2008 Nov; 100(5):762-5. PubMed ID: 18989518
[TBL] [Abstract][Full Text] [Related]
40. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
